Congress Materials – Winter Clinical Hawaii 2026
2026 Winter Clinical Hawaii | Jan 16-21 | Maui, HI
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Durability of Response to the Targeted Oral Peptide Icotrokinra for High-Impact Site Psoriasis: 1-Year ICONIC-TOTAL Findings
This poster will be available after January 16th 2026
Durable Inhibition of Structural Damage Progression and Improvements in Joint Disease Activity With Guselkumab in Active and Erosive Psoriatic Arthritis: Week 48 Results From APEX
This poster will be available after January 16th 2026
Efficacy and Safety of Icotrokinra Through Week 24 in Participants with Moderate-to-Severe Plaque Psoriasis: Pooled Results From ICONIC-ADVANCE 1&2
This poster will be available after January 16th 2026
Maintenance of Response With Icotrokinra, a Targeted Oral Peptide, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Randomized Treatment Withdrawal in Adults (Weeks 24-52) and Continuous Treatment in Adolescents (Through Week 52) From the Phase 3, ICONIC-LEAD Trial
This poster will be available after January 16th 2026
SPECTREM: Guselkumab Patient-Reported Outcomes Across Multiple High-Impact Sites in Participants With Low BSA, Moderate Psoriasis: Psoriasis Symptoms and Signs Diary Deep Dive
This poster will be available after January 16th 2026
SPECTREM: Skin Clearance Results Through Week 48 With Guselkumab in Participants With Low Body Surface Area, Moderate Plaque Psoriasis and Palmoplantar Involvement
This poster will be available after January 16th 2026
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.